Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.
| Author | |
|---|---|
| Abstract |
:
People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight, some are unable to make the necessary lifestyle changes or, despite making the changes, continue to gain weight. |
| Year of Publication |
:
2019
|
| Journal |
:
Trials
|
| Volume |
:
20
|
| Issue |
:
1
|
| Number of Pages |
:
633
|
| Date Published |
:
2019
|
| URL |
:
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3689-5
|
| DOI |
:
10.1186/s13063-019-3689-5
|
| Short Title |
:
Trials
|
| Download citation |
